Volunteers testing Pfizer’s COVID-19 vaccine speak of side effects. They felt like “after the monkey”

They told the media they had side effects, which would mean they received a real vaccine and not just a placebo. However, at this stage of testing, they shouldn’t know if that’s really the case.

Of the nearly 44,000 volunteers from six states in the United States, many found that they compared the vaccine’s side effects to a “severe monkey,” a condition people have after drinking too much alcohol. According to the Independent, for example, it was Glen Deshields, a 44-year-old from Austin, Texas.

Another volunteer, a 45-year-old Missouri woman who identified herself as Carrie, said she had a fever, headache, and body aches after the first injection. According to her, everything got worse after the second injection.

It is still unclear whether these are really vaccine side effects, as volunteers should not have such information at this stage of the test. At the same time, there are still questions as to whether the vaccine will be effective for older people or other ethnicities and how long we will be immune to it.

Russian counter

On the same day Pfizer and BioNTech announced their vaccine was 90% effective based on test results, Russia reported that their COVID-19 vaccine could be up to 92% effective.

The Moscow National Research Center for Epidemiology and Microbiology, which developed a vaccine called Sputnik V, tested 16,000 volunteers. However, several scientists say these reports are premature, as clinical trials of the Russian vaccine are not yet at the American stage.

Although the Sputnik data are based on fewer vaccinated people and fewer positive cases, they confirm promising results. The third phase of the clinical trial is being tested in Belarus, the United Arab Emirates, Venezuela and India. According to Russian scientists, it wasn’t there “No unexpected adverse events“.

The three greatest hopes

Vaccines against the novel coronavirus are being developed by hundreds of laboratories around the world, a dozen of which are in the final stages of testing. Certainly the most promising are the Sputnik V vaccines, those from Pfizer and BioNtech, as well as the Oxford vaccines. There are also significant differences between them.

The Pfizer vaccine injects part of the virus’s genetic code to train the immune system. The other two use a harmless virus that has been genetically engineered to resemble a coronavirus. All of them require two doses, but the advantage of Sputnik is that it doesn’t need to be stored down to -80 degrees Celsius.

However, we must not forget what the goal of vaccine development is. “This is not a competition. We need all exams to be conducted to the highest possible standard,” said Professor Eleanor Riley of the University of Edinburgh.

According to them, Russian scientists are registering applications for vaccine supply totaling over 1.2 billion doses from more than 50 countries around the world. They claim to be able to produce 500 million batches every year.

COVID-19 will never completely disappear

The famous Italian scientist Giuseppe Remuzzi of the Negri Pharmacological Research Institute in Milan also points out that the vaccine will not completely eliminate the disease. Whatever the COVID-19 vaccine, it will still be “more like the flu vaccine than the polio vaccine.”

Remuzzi expects the world’s population to receive one or more vaccines, which means humanity will be largely immunized within a few years, but also “only on condition that current measures are followed”, including wearing masks, social distancing and frequent. hand washing.

According to an Italian expert, COVID-19 will be common “like a cold” in the future. At the same time, however, Remuzzi said there are “too many variables” and therefore the future development of the pandemic is “impossible to predict”.

© SITA Slovak news agency, operator of the news portal webnoviny.sk. All rights reserved.